• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Pres & COO-Eastern Operations Forthuber Stephen M converted options into 2,760 shares and sold $1,135,599 worth of shares (18,820 units at $60.34), decreasing direct ownership by 3% to 535,182 units (SEC Form 4)

    5/20/25 4:15:10 PM ET
    $RDNT
    Medical Specialities
    Health Care
    Get the next $RDNT alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Forthuber Stephen M

    (Last) (First) (Middle)
    C/O RADNET, INC.
    1510 COTNER AVENUE

    (Street)
    LOS ANGELES CA 90025

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    RadNet, Inc. [ RDNT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Pres & COO-Eastern Operations
    3. Date of Earliest Transaction (Month/Day/Year)
    01/04/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 01/04/2024 M 1,380(1) A (1) 552,622 D
    Common Stock 01/04/2025 M 1,380(1) A (1) 554,002 D
    Common Stock 05/16/2025 S 18,820 D $60.34 535,182 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (1) 01/04/2024 M 1,380 (1) (1) Common Stock 1,380 $0 1,380 D
    Restricted Stock Units (1) 01/04/2025 M 1,380 (1) (1) Common Stock 1,380 $0 0 D
    Explanation of Responses:
    1. On January 4, 2022, the reporting person was granted a target number of restricted stock unit ("RSU") subject to performance and time vesting. Each RSU represents a contingent right, upon vesting of the RSU, to receive one share of RadNet common stock and/or the cash equivalent of such share. 2,760 RSUs vested as to the performance vesting, and such RSUs vest in two equal annual installments on January 4, 2024 and January 4, 2025. Transaction reflects the settlement of 1,380 vested RSUs into shares of common stock on each of January 4, 2024 and January 4, 2025.
    /s/ Jose Gamez, Attorney-in-Fact 05/20/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $RDNT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RDNT

    DatePrice TargetRatingAnalyst
    6/13/2025$69.00Buy
    B. Riley Securities
    3/5/2025$85.00 → $65.00Outperform → Strong Buy
    Raymond James
    9/6/2024$57.00 → $79.00Equal Weight → Overweight
    Barclays
    3/6/2024$48.00Equal Weight
    Barclays
    8/31/2023$40.00Buy
    Truist
    3/31/2023$30.00Market Outperform
    CJS Securities
    3/3/2023$30.00Mkt Perform → Outperform
    Raymond James
    8/12/2021Outperform → Market Perform
    Raymond James
    More analyst ratings

    $RDNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • B. Riley Securities initiated coverage on RadNet with a new price target

      B. Riley Securities initiated coverage of RadNet with a rating of Buy and set a new price target of $69.00

      6/13/25 7:50:00 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet upgraded by Raymond James with a new price target

      Raymond James upgraded RadNet from Outperform to Strong Buy and set a new price target of $65.00 from $85.00 previously

      3/5/25 7:50:00 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • RadNet upgraded by Barclays with a new price target

      Barclays upgraded RadNet from Equal Weight to Overweight and set a new price target of $79.00 from $57.00 previously

      9/6/24 7:50:42 AM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, Chief Science Officer Sorensen Alma Gregory gifted 5,600 shares, decreasing direct ownership by 0.48% to 1,165,345 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      6/18/25 4:15:24 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Director Swartz David L was granted 2,699 shares, increasing direct ownership by 2% to 176,766 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      6/11/25 6:58:58 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • Director Spurlock Gregory E. was granted 2,699 shares, increasing direct ownership by 104% to 5,290 units (SEC Form 4)

      4 - RadNet, Inc. (0000790526) (Issuer)

      6/11/25 6:57:48 PM ET
      $RDNT
      Medical Specialities
      Health Care

    $RDNT
    SEC Filings

    See more
    • RadNet Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - RadNet, Inc. (0000790526) (Filer)

      6/12/25 4:20:27 PM ET
      $RDNT
      Medical Specialities
      Health Care
    • SEC Form EFFECT filed by RadNet Inc.

      EFFECT - RadNet, Inc. (0000790526) (Filer)

      5/22/25 12:15:18 AM ET
      $RDNT
      Medical Specialities
      Health Care
    • SEC Form 424B3 filed by RadNet Inc.

      424B3 - RadNet, Inc. (0000790526) (Filer)

      5/21/25 5:10:55 PM ET
      $RDNT
      Medical Specialities
      Health Care